40. Brain Cancer Traced Back to Fused Genes

Genetic flaw sheds new light on the origin of this deadly cancer.

By Jennifer BerglundJan 21, 2013 8:47 PM
Glioblastoma invades the cerebral cortex. | BSIP / Photo Researchers


Sign up for our email newsletter for the latest science news

Glioblastoma, the most common and aggressive type of brain cancer, has long resisted treatment. But now, with the finding that glioblastoma can be triggered when two genes fuse, a targeted therapy to reverse the disease may be a step closer.

The insight was reported last September, when oncologists described a merger between two specific genes in 3 percent of the roughly 10,000 glioblastoma cases diagnosed each year. Similar mergers between other gene pairs, they hypothesized, could account for a significant portion of those with the disease. The discovery sheds new light on the origin of this deadly cancer, suggesting that therapies have largely failed because they are aimed at the wrong target.

The mergers occur during DNA replication, when matching segments of otherwise disparate genes mistakenly pair up. The fused gene in turn produces abnormal proteins that destabilize entire chromosomes, resulting in aggressive cancers. “These alterations are incredibly important in promoting cancer,” says Columbia University Medical Center oncologist Antonio Iavarone, who documented the process in his lab.

Iavarone is now exploring a new approach to treating glioblastoma. His team infused mice with cells transformed by the fused genes. Then he medicated the animals with AZD-4547, an experimental drug that targets the abnormal proteins. The treated mice lived twice as long as untreated ones.

1 free article left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

1 free articleSubscribe
Discover Magazine Logo
Want more?

Keep reading for as low as $1.99!


Already a subscriber?

Register or Log In

More From Discover
Recommendations From Our Store
Shop Now
Stay Curious
Our List

Sign up for our weekly science updates.

To The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Copyright © 2023 Kalmbach Media Co.